OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2023-12-31-accounts

REGISTERED CHARITY NUMBER: 1188749 Report of the Trustees and Unaudited Financial Statements for the period 1 January 2023 to 31 December 2023 ST FRANCIS LEPROSY GUILD

Contents

Contents
Board of Trustees 03
About leprosy - a curable disease 06
St Francis Leprosy Guild (SFLG) 07
Vision and Mission 08
Objectives and aims 09
Operational activities 09
Fundraising and performance 13
Structure, governance, and management 17
Independent examiner’s report 19
Financial Statements 20

Abbreviations

CBCEW Catholic Bishops’ Conference of England and Wales CIO Charitable Incorporated Organisation GDPR General Data Protection Regulation LSHTM London School of Hygiene & Tropical Medicine NGO Non-Governmental Organisation SFLG St Francis Leprosy Guild WHO World Health Organization

2

Reference and administrative details for the year 01 January 2023 to 31 December 2023

The trustees present their report with the financial statements of the charity for the year ended 31 December 2023. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice, applicable to charities preparing their accounts. This is in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland.

Board of Trustees

Mr Michael Forbes Smith (Chair of Trustees up to May 2023)

Mr Edward Reed (Chair of Trustees from May 2023)

Mr Michael Heathcote (Treasurer)

Mr Liam Allmark

Mrs Clare Barton

Dr Margaret Burgess

Very Reverend Father Michael Copps OFM

Dr William Dibb

Professor Noel Gill

Professor Robin Graham-Brown (stood down in May 2023)

Ms Nalini Nathan (stood down in February 2023)

Ms Cecilia Taylor-Camara

Chief Executive Officer

Mrs Clare McIntosh (resigned in April 2023)

Acting Director

Katharine Jones (appointed April 2023)

St Francis Leprosy Guild Annual Report 2023

3

Brief details about each of the current trustees are as follows:

Chair (up to May 2023) - Michael Forbes Smith. A former British soldier 1971-1978; diplomat 1978-2004; ambassador to Tajikistan 2002-2004 and Director General of the Chartered Institute of Arbitrators 2006-2012.

Chair (from May 2023) - Edward Reed. A solicitor and partner at Macfarlanes, advising internationally mobile families on their asset structuring, personal tax, succession planning, wills and trusts, with an affinity for civil law issues generally. Is trustee of a number of charities.

Honorary Treasurer - Michael Heathcote. A Fellow of the Institute of Chartered Accountants, a Freeman of the City of London, and a Liveryman in the Worshipful Company of Wheelwrights. Committed to charities that promote and support humanitarian, educational and cultural projects.

Liam Allmark. A senior Policy and Research Analyst for international affairs at CBCEW. He supports the bishops in their work on a range of global issues, including peacebuilding, promoting human rights, and supporting refugees. Travels regularly in support of the local church overseas, including Palestine, Israel, Myanmar, Iraq and Thailand.

Clare Barton. A solicitor who has worked both at a major City law firm and as an in-house lawyer. A Governor at her local school since 2013 and Chair of the school’s Admissions Committee. CAFOD and MISSIO representative for her local parish. Safeguarding Lead from May 2023.

Dr Margaret Burgess. A lecturer on leprosy at LSHTM. She holds a Diploma in Tropical Nursing and based her MSc dissertation on her experiences living in a leprosy colony in Nepal. In 2008 she was awarded a DSSc from Brunel University. She is a trustee of the Friends of Arundel Cathedral, the Society of Saint Augustine of Canterbury, co-chair and trustee of the Centenary Appeal, the Sussex Community Foundation and Promise Nepal. Safeguarding Lead from May 2023.

Father Michael Copps. A member of the Order of Friars Minor (OFM) since 1965; Guardian and Novice Master in the community in Chilworth, Surrey 1981 to 1990; subsequently served as a parish priest in Nottingham, St Antony’s, Forest Gate and St Francis, Stratford, including as Guardian of the Community 1994-1997. He was Provincial of the Friars in England 2005-2014 and elected Custos in 2018.

Dr William Dibb. A retired consultant clinical microbiologist and infection control doctor. Also, the Chair of Laboratories and Infection Prevention and Control for many years. Wide infection experience abroad, including in the developing world. A keen medical historian with a special interest in the history of infection.

Professor Noel Gill. An infectious disease epidemiologist and honorary professor at LSHTM; worked at Public Health England’s National Infectious Disease Surveillance Centre leading the HIV & STI team 1980- 2020. After retirement he returned part-time from 2020 through 2021 to assist with the response to the COVID-19 emergency.

Professor Robin Graham-Brown. A (mostly) retired Consultant Dermatologist at University Hospitals of Leicester and the Gibraltar Health Authority 1983-2018; Editor, British Journal of Dermatology 2000-2004; President, British Association of Dermatologists 2005-2006, and Dowling Club 2009-2010; combines active clinical practice with research, teaching, authorship and clinical management at trust board level; he is Chair of Trustees of a hospice in the East Midlands. Safeguarding Lead up to May 2023.

Nalini Nathan. General Secretary for the Conference of Religious in England and Wales. Prior to this she worked at CAFOD for seven years in various roles. Plays an active role in social justice. She has an MA in Contemporary Ethics and is a trustee of another Catholic charity.

Cecilia Taylor-Camara. Until 2020, a senior policy adviser in the Office for Migration Policy at CBCEW; strategic lead and adviser on migration, racial justice and human trafficking. She continues to work on combatting human trafficking and raising awareness of the crime.

St Francis Leprosy Guild Annual Report 2023

4

Principal address

73 St Charles Square London W10 6EJ

Registered charity number: 1188749

Independent examiner

PKW Accountancy Ltd Second Floor 1 Church Square Leighton Buzzard Bedfordshire LU7 1AE

Bankers

CAF Bank Limited Kings Hill West Malling Kent ME19 4TA

Barclays Bank 1 Churchill Place London E14 5HP

Accountants

Waugh & Co Chartered Accountants 51 High Street Arundel West Sussex BN18 9AJ

St Francis Leprosy Guild Annual Report 2023

5

About leprosy – a curable disease

Leprosy, also known as Hansen’s disease, is a chronic, infectious disease caused by the bacterium Mycobacterium leprae discovered in 1873 by the Norwegian physician Gerhard Armauer Hansen. Leprosy affects the skin, peripheral nerves and the upper respiratory tract. Leprosy can affect anyone, at any age, but it is linked to poverty and malnutrition. Leprosy continues to be a threat to public health in low and middleincome countries. Despite the widespread fear that leprosy is highly contagious, it is in fact diffcult to catch and 95% of us are resistant to developing the disease. It is thought that leprosy is spread by droplet infection (coughing and sneezing) during prolonged and close contact with untreated individuals who have the disease. People who lack access to clean water, sanitation and hygiene, those with compromised immune systems or who are malnourished are also more likely to catch it. Leprosy is a disease of poverty.

Leprosy is challenging to diagnose, especially at the early stages. It attacks peripheral nerves, which destroys the ability to feel pain. The lack of sensation leads to trauma, ulcers and other infections. Left untreated, these infections can lead to permanent disability, disfigurement and amputations. Even those treated for leprosy and who are no longer infectious can still develop complications over their lifetime. Leprosy can also cause blindness, facial disfigurement and the clawing of hands and feet. The visible disability and disfigurement caused by leprosy over the years means the disease is greatly feared. Many leprosy-affected people (including their families and children) are subjected to stigma and discrimination and excluded from society. Since the earliest of times, fear and ignorance has allowed society to discriminate against and deny leprosy-affected people their right to a full and normal life.

In addition, outdated discriminatory laws mean that people with leprosy can be forcibly evicted from their homes, livelihoods, and places of work. In some parts of the world, leprosy is a reason for divorce. Due to these terrible injustices, people with leprosy may not come forward for medical treatment, putting themselves, their families and communities at greater risk. A United Nations Special Rapporteur (operating under the aegis of the UN High Commissioner for Human Rights) is working to identify and repeal these laws.

Leprosy is curable today with a course of antibiotics known as Multidrug Therapy (MDT) which first became available in 1981 and has been distributed free of charge worldwide to patients since 1991.

Following the introduction of MDT, around seventeen million people have been released from treatment for leprosy. However, since the early 2000s, the downwards trend of numbers diagnosed and treated has stagnated at around 200,000 per year. In addition, the number of people contracting the disease who are undiagnosed, or living with its effects, such as blindness, amputated limbs or the stigma and discrimination associated with it, is many millions.

The WHO monitors leprosy worldwide and has developed a global leprosy strategy, which is reviewed by experts every five years. The goal of the current strategy is to achieve Zero Leprosy. SFLG, along with the rest of the global leprosy community, is aligned with the WHO strategy. The final mile to ending leprosy is proving to be the toughest and most challenging. According to WHO, there are between two and five million undiagnosed (disfigured and disabled) leprosy-affected people worldwide. So, although we can see an end to this terrible and ancient disease, there remains plenty to be done to achieve Zero Leprosy. SFLG has existed for 129 years but it is this ongoing challenge which keeps us focused.

St Francis Leprosy Guild Annual Report 2023

6

St Francis Leprosy Guild (SFLG)

SFLG was founded on 23 October 1895. The moving spirit was Kate Marsden, a nursing heroine determined to help relieve the desperate plight of leprosy sufferers throughout the world. Until MDT became widely available through the WHO in the 1990s, SFLG’s primary activity was the compassionate support of leprosy villages, hospitals, clinics or communities that treat or care for leprosy sufferers and their dependants.

In 2017, SFLG embarked on “A Pilgrimage of Hope” combining a commitment to play our part in the WHO’s developing strategies, currently (2021-30) “Towards Zero Leprosy”, with a determination to increase the charity’s professionalism and grow the voluntary income needed to meet that challenge.

As part of that process, SFLG became a Charitable Incorporated Organisation (CIO) in 2020. SFLG’s key strategic focus is now the detection and diagnosis of people affected by leprosy as early as possible while maintaining the material support that it has provided to leprosy sufferers and their dependants for the past 129 years. SFLG’s activities and projects, in particular its focused, intensive Active Case-Finding programme, are now making an important contribution to ascertaining, diagnosing, treating, monitoring and rehabilitating people with leprosy: making our contribution towards stopping the disease in its tracks and preventing more avoidable suffering. In addition, through its membership of the Leprosy Research Initiative, SFLG has contributed towards innovative applied research projects.

SFLG is now a member of several global organisations working together to break the transmission of leprosy and to end leprosy for good, including the Global Partnership for Zero Leprosy, the Neglected Tropical Diseases NGO Network and ILEP (The International Federation of Anti-Leprosy Associations) which covers over sixty countries and thousands of projects. Through these memberships, SFLG has direct relationships with the WHO and the United Nations.

SFLG is the UK’s only Catholic leprosy charity. Although a Roman Catholic charity, SFLG has never made any distinction regarding the creed or denomination of our beneficiaries, nor of race, colour, gender or age. We are proud of our heritage and, conscious of the trust our benefactors and donors place in us, we are invigorated by the unique opportunity we have before us to play our part in ending leprosy for good.

We look forward to celebrating our 130th anniversary during the 2025 Jubilee Year, which also marks the penultimate in a series of Franciscan anniversaries, the 800th anniversary of the Canticles of the Creatures. The Annual Mass and Assembly to mark this will be held at Westminster Cathedral on Saturday 4 October 2025.

St Francis Leprosy Guild Annual Report 2023

7

Vision and Mission

Our vision is a leprosy-free world.

Our mission is to end leprosy’s devastating impact everywhere for everyone.

To do this, we work with dedicated partners around the world to help find and cure people with leprosy before they develop disability, to care for people living with leprosy’s devastating impact and to fund research into new ways to end leprosy.

In 2023, SFLG worked in fourteen countries supporting over forty centres, research activities and programmes.

Where we work in Africa

Where we work in Brazil

Where we work in Asia

St Francis Leprosy Guild Annual Report 2023

Objectives and aims

SFLG’s objectives are as follows:

  1. funding organisations giving relief and assistance to persons with leprosy or disabled as a result of leprosy, their families, and dependants throughout the world;

  2. funding activity towards prevention and control of the disease of leprosy, including relevant investigations and research of the causes, treatment, and prevention of this disease, and

  3. carrying out or funding the professional education of those engaged in the prevention, diagnosis, and treatment of leprosy.

In our activities as described below, the trustees consider that they have complied with their duty to have due regard to the guidance issued by the Charity Commission, including on public benefit.

Operational activities

In 2023, SFLG continued to categorise its activities under the TRACE acronym.

Training

Supporting undergraduate and postgraduate leprosy-specific specialist skills through short or long-term training and learning opportunities for any grade of healthcare worker to develop their potential as future specialist leaders committed to Zero Leprosy.

Research

Supporting applied research into leprosy transmission, prevention, and care (in collaboration with the Leprosy Research Initiative).

Active Case-Finding

Detecting new leprosy cases by screening all members of at-risk populations.

Care

Supporting the care of leprosy cases and their contacts through providing inpatient and outpatient treatment, surgery, rehabilitation, and long-term care for people diagnosed with leprosy, their families, and others living in or near their households.

Emergency Support/Capital Equipment

Investing capital in leprosy-related equipment, maintenance of facilities and rebuilding. Maintaining an Emergencies Reserve to meet any needs that may arise due to adversity.

Training

It is difficult to recruit healthcare practitioners to work in a highly stigmatized disease area like leprosy. Leprosy treatment lacks the prestige and higher salaries of many medical disciplines. Our aim is to support opportunities to fill this deficiency gap and increase the leprosy care experience of healthcare professionals. For this reason, funding leprosy-specific training is part of SFLG’s activity.

Historically, SFLG has funded short-term visiting electives for students to spend time in one of its centres to develop their knowledge of leprosy. In 2023, SFLG did not provide funding for such an elective.

St Francis Leprosy Guild Annual Report 2023

9

Research

SFLG is an Associate Member of the Leprosy Research Initiative (LRI), a global joint venture of twelve leprosy NGOs with the shared goal of working together to achieve Zero Leprosy. LRI consolidates leprosy research worldwide and prioritises future projects to deliver the vision of a world free from leprosy. SFLG’s membership of LRI ensures our research investment is distributed competitively, is independently peer-reviewed, and is expertly evaluated.

SFLG is funding three significant projects through this relationship:

  1. The development of a mobile app to assist healthcare providers in Eastern India to screen suspected leprosy cases based on multiple criteria, and to record data for follow up. As leprosy has a very long incubation period (three to twenty years), people who may have been exposed to leprosy need to be checked regularly for many years to come. The app aims to support the diagnosis of other diseases including tuberculosis.

  2. The testing of fabric boots in West Bengal and Utter Pradesh, affectionately known as the Beckham Boot, as an alternative treatment for people with leprosy who have leg ulcers. This treatment will be tested against the current practice of using plaster casts, which can be uncomfortable and sub-optimal.

  3. Engaging persons affected by leprosy in Ghana to become agents of change in their community by becoming leprosy peer mentors to support early case detection, disease management and disability inclusion, with a view to reducing stigma and improving mental health.

Active Case-Finding

Leprosy is a highly stigmatized, insidious, transmissible disease. It has an incubation phase of three to twenty years making its mode of transmission almost impossible to trace. Leprosy may not cause any pain and discomfort in the early stage, so people do not seek medical help. Once it is apparent, stigma or legal consequences frequently act as a powerful disincentive to seeking treatment. Yet early diagnosis and treatment would prevent the disability, stigma and disfiguration that can develop, and it would prevent others catching it.

To work towards the goal of Zero Leprosy, in 2020 SFLG began supporting selected partners to detect new leprosy cases early by conducting door-to-door screening of all members of disadvantaged populations at higher risk of leprosy. The aim of this population-based Active Case-Finding (PB-ACF) is to screen all members of a target population over a three-year period, through a series of case-finding campaigns in local areas where the incidence of leprosy may be relatively high.

During 2021, SFLG sponsored the following six PB-ACF projects:

  1. Dhanjuri Leprosy Centre (Bangladesh)

  2. ALERT India

  3. Bombay Leprosy Project (India)

  4. The Leprosy Mission in Nepal

  5. New Hope Rural Leprosy Trust (India) and

  6. Marie Adelaide Leprosy Centre (Pakistan).

St Francis Leprosy Guild Annual Report 2023

10

Building on this work, in 2022 SFLG invited partners to propose new PB-ACF projects. SFLG agreed to support three more projects, which launched between September and November 2022, in the following areas:

  1. The Meherpur District, Bangladesh (with The Leprosy Mission of England and Wales);

  2. Tamil Nadu, India (The Holy Family Hansenorium);

  3. The Yumbe and Zombo districts, Uganda (with The German Leprosy and Tuberculosis Relief Association).

In 2023, SFLG and its partners continued to implement the nine PB-ACF projects, each of which have delivered significant results. Since the launch of the PB-ACF programme, 441,573 people have been screened in areas with limited access to healthcare and 417 new cases of leprosy were found. Sixty-four skin camps were undertaken in India alone. Finding these cases early will prevent almost all from developing permanent disabilities. During the projects’ implementation period, over three hundred healthcare workers were trained in the skills needed to spot the early signs of leprosy.

Care

SFLG’s principal activity since 1895 has been supporting treatment and rehabilitation for people with leprosy, together with awareness campaigns to combat stigma and remove the fear and misunderstanding surrounding the disease. Leprosy-affected individuals require a range of support including reconstructive surgery, physiotherapy, social rehabilitation and training in new skills, and, in some cases (where individuals have been rejected by their communities), lifelong care is needed. SFLG supports the holistic care of people affected by leprosy and their contacts through the provision of inpatient and outpatient treatment and care. Our partners include hospitals, clinics, leprosy villages and community-based rehabilitation organisations.

In 2023, SFLG supported thirty-one partner organisations in fourteen countries with over 15,400 carefocused interventions. The objective of all these interventions is to enable people affected by leprosy to return to their communities and make their contribution to their family life and society. In addition, our partners diagnosed 1,438 new cases of leprosy in 2023.

Some of SFLG’s key projects include:

St Francis Leprosy Guild Annual Report 2023

11

Emergency relief

We maintain an Emergencies Reserve to meet any needs that may arise due to adversity such as natural disasters affecting our partners, or the people affected by leprosy with whom we work. In 2023, thankfully, none of our centres needed emergency relief. The budget was used instead on capital equipment such as a motorcycle, solar panels, and water tanks.

Expenditure by TRACE in 2023 £383,152

----- Start of picture text -----
T raining £2,410
R esearch grants £60,020
C are £212,072
A ctive Case-Finding £108,650
E mergency/ Equipment £0
----- End of picture text -----

Partner Due Diligence

SFLG’s Executive Team carried out due diligence on any potential partners to ensure:

SFLG’s Executive team also adopts a risk-rated approach to due diligence. Risk factors include:

The results of any due diligence do not last indefinitely. In cases where beneficiaries are supported for a significant period, additional due diligence is undertaken if there is a change of circumstances that might impact the partner or, in any case, every two years.

St Francis Leprosy Guild Annual Report 2023

12

Fundraising and performance

In 2023, SFLG generated income of £391,407, less than half the £979,829 raised in 2022. However, in 2023, aware of the imperative to reduce the reliance on legacy income, individual donations were increased to £218,528 from £147,554 in 2022. Legacy income decreased by £651,402 in 2023 to £141,712 compared to £793,114 in 2022.

Total Income 2023 — £391,407

----- Start of picture text -----
Legacies £141,712 Investment £19,208
Bank interest £11,959
Gift aid £18,991
Donations £199,537
----- End of picture text -----

Individual giving (donations and Gift Aid)

The main means of introducing new donors to SFLG has been through inserts in various press titles. In 2023, a new initiative, Partially Addressed Mail or “PAM”, was tested in the spring and autumn. Given their lack of success in 2023, the use of both press inserts and PAM will be discontinued in 2024.

In terms of raising funds, SFLG issued three direct mail appeals in 2023: a late summer appeal including the Annual Review for 2022; an autumn appeal including the Autumn Newsletter for 2023, and a Christmas appeal in support of Active Case-Finding in Bangladesh. All direct mail appeals in 2023 were very wellsupported. In 2023, SFLG reviewed its marketing and fundraising strategy with an external fundraising strategist, to ensure donor diversification.

SFLG is registered with the Fundraising Regulator and complies with its standards. No complaints were received about any aspect of fundraising in the reporting period. SFLG is compliant with the GDPR in all its activities and no data is sold to other organisations.

The Annual Mass and Assembly celebrating SFLG’s 128th anniversary was due to take place at Westminster Cathedral, London, SW1, on 4 October 2023. The event regrettably had to be postponed due to rail and tube strikes. The Annual Mass and Assembly is ordinarily a great opportunity for SFLG to meet its supporters and the trustees were sorry not to be able to thank our supporters in person on this occasion.

St Francis Leprosy Guild Annual Report 2023

13

Legacies

SFLG was fortunate to receive generous support from its benefactors. In 2023, SFLG received four legacies totalling £141,712 (compared with £793,114 in 2022).

The details of SFLG’s legators are captured in a Book of Remembrance and prayed for regularly. In addition, the names of legators are recorded in SFLG’s online Garden of Remembrance at https://www.stfrancisleprosy.org/remembrance.html.

Trusts

No trust fundraising was undertaken in 2023 and income from this source was not recorded. Trust fundraising recommenced in 2024 following an operational restructuring (see Staff and restructuring below).

Investment income

Investment income decreased to £19,208 in 2023 compared with £20,187 in 2022.

Volunteers

SFLG is very privileged to have a committed, volunteer Board of Trustees, many of whom are leaders in their fields. Its trustees gave extensively of their time. The total value of the trustees’ time cannot be estimated under normal measures but by any assessment it is of considerable value.

Staff and restructuring

At the start of 2023, SFLG employed a full-time Chief Executive Officer (Clare McIntosh), Finance Director (Servet Ege), Programmes Manager (Charlotte John), Administrator (Rosanna Threakall) and Community Fundraiser (Eileen Murray).

In April 2023, to mitigate the risk from unsustainable workloads and payroll costs, the trustees restructured the Executive team. The roles of Chief Executive Officer and Finance Director were made redundant. An Acting Director was appointed on a consulting basis to oversee SFLG’s operations and, at the recommendation of the Honorary Treasurer, external accountants were appointed.

Overview of operations

Acting Director

Throughout 2021 and 2022, SFLG outsourced its communications (website development and graphic design and PR) to Katharine Jones. In April 2023, the trustees invited Katharine to step in as Acting Director, to steer and bring stability to SFLG’s operations. She remained in this role throughout 2023.

Accounting

In 2023, the trustees outsourced accounting to Waugh & Co. Chartered Accountants. Edmund Chavasse of Waugh & Co has handled the charity’s day-to-day accounts since May 2023.

Data Management

At the end of 2022, the trustees commissioned a new Customer Relations Management Database (CRM), Donorfy. All donor data from previous databases were transferred to Donorfy. To ensure the integrity of the data, the trustees engaged an experienced data manager on a consultancy basis in May 2023 to manage the CRM. This measure has transformed the quality and utility of the charity’s data. The trustees believe that high quality data handling, security and GDPR compliance are imperative.

St Francis Leprosy Guild Annual Report 2023

14

Donor relationships and donor data

Between July 2021 and March 2024, an external agency provided donation handling and banking services to SFLG. The agency was responsible for processing donations, donor and supporter relationships and handling enquiries from the website. In 2023, the trustees decided that these activities could be dealt with more efficiently in-house, and notice was given to the external agency (which took effect from March 2024). In November 2023, an experienced bookkeeper was engaged to manage the charity’s donor relationships, process all donations and update data on Donorfy.

Policy

Throughout 2023, SFLG has updated its policies in line with Charity Commission best practices. Rosie Threakall was promoted from Administrator to Head of Secretariat and Policy to manage the ongoing need for policy development.

Fundraising

During 2023, an external fundraising strategist was engaged to advise the charity on how to diversify and grow its fundraising to mitigate its reliance on legacies and develop a sustainable fundraising platform. Following this fundraising review, in December 2023 the trustees decided that there was limited scope for raising funds from local schools and churches and the Community Fundraiser’s role was made redundant.

Social Media

In 2023, to raise and increase the charity’s profile through its social media channels (Facebook, Instagram, LinkedIn and Twitter/X), a social media expert was hired to maintain our outputs.

Executive and extended teams

At the end of 2023, the charity had two full-time employees (Charlotte John, Programmes Manager, and Rosanna Threakall, Secretariat Manager) and a full-time Acting Director. Part-time contractors and consultants provided all other operational requirements.

The trustees would like to thank the commitment of the Executive team and the extended team of contractors who, between them, have transformed SFLG’s operations during 2023.

In 2023, the costs of employing staff (pension, taxes and wages) and the restructuring increased to £190,137 from £163,670 in 2022. The cost benefits of the restructuring will be seen in 2024.

Operating Costs

SFLG pays close attention to the control, and, where possible, reduction, of its annual operating costs.

Rent and utilities increased to £11,751 in 2023 from £7,667 in 2022. Postage and stationery costs increased to £5,017 in 2023 from £3,589 in 2022. IT and Support Costs decreased to £6,371 from £8,631 in 2022. Insurance increased to £1,809 from £1,388 in 2022. Travel costs decreased to £5,498 from £9,672 in 2022. Legal and professional fees decreased to £16,074 from £18,130 in 2022. Total support costs were £148,138 in 2023 including the cost of part-time contractors and consultants.

The cost of maintaining donors and finding new donors increased to £145,889 in 2023, up from £136,901 in 2022. The increase was due to the Partially Addressed Mail initiative which will be discontinued in 2024. The cost benefits in relation to the reduced donor acquisition will be seen in 2024.

St Francis Leprosy Guild Annual Report 2023

15

Safeguarding

SFLG’s employees have little direct contact with people with leprosy, vulnerable adults, or children, but the prime purpose of the partner organisations it supports is the daily care of such people. The Board of Trustees requires that all those conducting projects on SFLG’s behalf comply with SFLG’s Safeguarding Policy and Code of Conduct. All the partner organisations that SFLG worked with in 2023 confirmed in writing that they were in full compliance with both documents. Compliance with SFLG’s Safeguarding Policy and Code of Conduct will continue to be an absolute requirement for any future potential partner organisations. We continue to work closely with our partners to ensure safeguarding is prioritised and mainstreamed into our programmes and projects.

In May 2023, following the retirement as a trustee of Professor Robin Graham-Brown, he was replaced as Safeguarding Lead by Clare Barton and Dr Margaret Burgess who became Joint Safeguarding Leads.

Accounting practice

These accounts have been prepared on an accrual basis.

Reserves policy

As at 31 December 2023, SFLG held unrestricted reserves of £914,172.

Trustees have reviewed the activities and commitments of the charity and determined that, to ensure continuity of activities and honour contractual liabilities, a level of free reserves should be maintained at between £500,000 and £1 million.

Investment policy and objectives

The trustees are eager to generate a level of returns from reserves without taking on unacceptable risk. Their approach is to accept a level of medium risk, with a balance sought between realising a target income and achieving capital growth. Investments are divided among equities, bonds, cash and alternatives. The portfolio is externally managed by investment managers who are regulated by the Financial Conduct Authority. Updates on the value of the portfolio are provided to SFLG quarterly. At least once a year the Board of Trustees discusses the performance of the investments with SFLG’s investment manager, as well as the prevailing and anticipated economic conditions and a forecast of future trends, and it looks at future cash requirements to be funded by the investments. Trustees review the level of risk annually. In the implementation of this policy, the trustees follow the Charity Commission guidance for the investment of charitable funds.

Risk assessment

The trustees have assessed the major risks to which the charity is exposed, those related to the governance, operations and finances of SFLG, as well as those relating to the external economic environment and the regulatory framework in which SFLG operates. The trustees review these risks on a regular basis and are satisfied that systems are in place to mitigate exposure to major risks from within SFLG.

St Francis Leprosy Guild Annual Report 2023

16

Structure, governance and management

The charity is controlled by its governing document, the Constitution of St Francis Leprosy Guild of 14 May 2020.

Charity constitution

The charity is a Charitable Incorporated Organisation that was established on 25 March 2020.

Charitable structure

SFLG changed its charitable status from an Unincorporated Association to a Charitable Incorporated (Foundation) Organisation (CIO) on 25 March 2020.

Appointment of trustees

Under SFLG’s constitution, up to twelve trustees may be appointed for up to three terms of three years but may not be reappointed for a fourth term until after an interval of at least one year. Trustees are appointed based on suitable qualifications and experience. They are briefed on the activities of SFLG and their responsibilities as trustees by the existing trustees. They manage the affairs of the CIO and exercise individually and jointly the powers set out in the Constitution. The Provincial or Custos of the Order of Friars Minor is Spiritual Director and a trustee ex officio. CBCEW nominates a trustee to represent them.

In 2023, two trustees, Professor Robin Graham-Brown and Ms Nalini Nathan, stood down from the Board. SFLG is very grateful for their long and valuable contribution.

The trustees’ skills audit is up to date.

All trustees give their time freely and no trustee remuneration was paid in the year. Details of trustee expenses and related transactions are disclosed in the notes to the accounts. Trustees are required to disclose all relevant interests at each meeting.

St Francis Leprosy Guild Annual Report 2023

17

Trustees’ responsibility statement

The trustees are responsible for preparing the Report of the Trustees and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice) including Financial Reporting Standard 102: the financial reporting standard applicable in the UK and Republic of Ireland.

The law applicable to charities in England and Wales, the Charities Act 2011, Charity (Accounts and Reports) Regulations 2008 and the provisions of the Constitution of SFLG require the trustees to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the charity and of the incoming resources and application of resources, including the income and expenditure, of the charity for that period. In preparing those financial statements, the trustees are required to:

The trustees are responsible for keeping proper accounting records which disclose with reasonable accuracy at any time the financial position of the charity and to enable them to ensure that the financial statements comply with the Charities Act 2011, the Charity (Accounts and Reports) Regulations 2008 and the provisions of the governing document. They are also responsible for safeguarding the assets of the charity and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

The trustees are responsible for the maintenance and integrity of the charity and financial information included on the charity’s website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

St Francis Leprosy Guild Annual Report 2023

18

Independent examiner’s report to the trustees of St Francis Leprosy Guild

I report to the trustees on my examination of the financial statements of St Francis Leprosy Guild (the Trust) for the year ended 31 December 2023.

Responsibilities and basis of report

As the charity trustees of the Trust, you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 (‘the Act’).

I report in respect of my examination of the Trust’s accounts carried out under section 145 of the Act and in carrying out my examination I have followed all applicable Directions given by the Charity Commission under section 145(5)(b) of the Act.

Independent examiner’s statement

Since your charity’s gross income exceeded £250,000 your examiner must be a member of a listed body. I can confirm that I am qualified to undertake the examination because I am a registered member of ICAEW which is one of the listed bodies.

I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:

  1. accounting records were not kept in respect of the Trust as required by section 130 of the Act; or

  2. the accounts do not accord with those records; or

  3. the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination.

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report to enable a proper understanding of the accounts to be reached.

St Francis Leprosy Guild Annual Report 2023

19

ST FRANCIS LEPROSY GUILD

STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT

FOR THE YEAR ENDED 31 DECEMBER 2023

Unrestricted
Restricted
funds
funds
2023
2023
Notes
£
£
Income from:
Donations and
legacies
2
357,347
2,893
Investments
3
31,167
-
Total income
388,514
2,893
Expenditure on:
Raising funds
4
329,020
-
Charitable activities
5
549,396
2,893
Total expenditure
878,416
2,893
Net gains/(losses) on
investments
10
11,064
-
Net movement in funds
(478,838)
-
Fund balances at 1 January
2023
1,393,010
-
Fund balances at 31
December 2023
914,172
-		 Total
Unrestricted
Restricted
funds
funds
2023
2022
2022
£
£
£
360,240
936,724
20,796
31,167
22,309
-
391,407
959,033
20,796
329,020
260,206
-
552,289
465,877
20,796
881,309
726,083
20,796
11,064
(145,592)
-
(478,838)
87,358
-
1,393,010
1,305,652
-
914,172
1,393,010
-		 Total
2022
£
957,520
22,309
979,829
260,206
486,673
746,879
(145,592)
87,358
1,305,652
1,393,010

The statement of financial activities includes all gains and losses recognised in the year.

The notes on pages 23 to 33 form part of these financial statements.

St Francis Leprosy Guild Annual Report 2023

20

ST FRANCIS LEPROSY GUILD

BALANCE SHEET

AS AT 31 DECEMBER 2023

2023 2022
Notes £ £ £ £
Fixed assets
Tangible assets 12 200 3,925
Investments 13 748,254 722,509
748,454 726,434
Current assets
Debtors 14 18,116 14,760
Cash at bank and in hand 201,578 670,965
219,694 685,725
Creditors: amounts falling due within
one year 15 (53,976) (19,149)
Net current assets 165,718 666,576
Total assets less current liabilities 914,172 1,393,010
Income funds
Unrestricted funds
Designated funds 17 - 353,621
General unrestricted funds 914,172 1,039,389
914,172 1,393,010
914,172 1,393,010
The notes on pages 7 to 17 form part of these financial statements.
The notes on pages 23 to 33 form part of these fnancial statements.

St Francis Leprosy Guild Annual Report 2023

21

ST FRANCIS LEPROSY GUILD

STATEMENT OF CASH FLOWS

FOR THE YEAR ENDED 31 DECEMBER 2023

2023
2022
Notes
£
£
£
Cash flows from operating activities
Cash (absorbed by)/generated from
operations
19
(485,873)
Investing activities
Purchase of tangible fixed assets
-
(2,708)
Purchase of investments
(182,114)
(137,474)
Proceeds from disposal of investments
167,433
126,518
Investment income received
31,167
22,309
Net cash generated from investing
activities
16,486
Net cash used in financing activities
-
Net (decrease)/increase in cash and cash
equivalents
(469,387)
Cash and cash equivalents at beginning of year
670,965
Cash and cash equivalents at end of year
201,578		 £
203,845
8,645
-
212,490
458,475
670,965

The notes on pages 23 to 33 form part of these financial statements.

St Francis Leprosy Guild Annual Report 2023

22

ST FRANCIS LEPROSY GUILD

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2023

1 Accounting policies

Charity information

St Francis Leprosy Guild is a Charitable Incorporated Organisation.

1.1 Accounting convention

The financial statements have been prepared in accordance with the Trust's governing document, the Charities Act 2011, FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the Charities SORP "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)" (effective 1 January 2019). The Trust is a Public Benefit Entity as defined by FRS 102.

The financial statements are prepared in sterling, which is the functional currency of the Trust. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of investments at fair value. The principal accounting policies adopted are set out below.

1.2 Going concern

At the time of approving the financial statements, the trustees have a reasonable expectation that the Trust has adequate resources to continue in operational existence for the foreseeable future. Thus the trustees continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3 Charitable funds

Unrestricted funds are available for use at the discretion of the trustees in furtherance of their charitable objectives.

Designated funds comprise funds which have been set aside at the discretion of the trustees for specific purposes. The purposes and uses of the designated funds are set out in the notes to the financial statements.

Restricted funds are subject to specific conditions by donors as to how they may be used. The purposes and uses of the restricted funds are set out in the notes to the financial statements.

1.4 Income

Income is recognised when the Trust is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received.

Cash donations are recognised on receipt. Other donations are recognised once the Trust has been notified of the donation, unless performance conditions require deferral of the amount. Income tax recoverable in relation to donations received under Gift Aid or deeds of covenant is recognised at the time of the donation.

Legacies are recognised on receipt or otherwise if the Trust has been notified of an impending distribution, the amount is known, and receipt is expected. If the amount is not known, the legacy is treated as a contingent asset.

St Francis Leprosy Guild Annual Report 2023

23

ST FRANCIS LEPROSY GUILD

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023

1 Accounting policies

(Continued)

1.5 Expenditure

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement, and the amount of the obligation can be measured reliably.

Expenditure is classified by activity. The costs of each activity are made up of the total of direct costs and shared costs, including support costs involved in undertaking each activity. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs which contribute to more than one activity and support costs which are not attributable to a single activity are apportioned between those activities on a basis consistent with the use of resources. Central staff costs are allocated on the basis of time spent, and depreciation charges are allocated on the portion of the asset’s use.

Governance and support costs have been allocated on a 50:50 basis between raising funds and grant allocations. The support costs for grant allocations are allocated on a grant payable basis.

1.6 Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computers 50% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the statement of financial activities.

1.7 Fixed asset investments

Fixed asset investments are initially measured at transaction price excluding transaction costs, and are subsequently measured at fair value at each reporting date. Changes in fair value are recognised in net income/(expenditure) for the year. Transaction costs are expensed as incurred.

1.8 Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

St Francis Leprosy Guild Annual Report 2023

24

ST FRANCIS LEPROSY GUILD

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023

2 Donations and legacies

Unrestricted
Restricted
funds
funds
2023
2023
£
£
Donations and gifts
215,635
2,893
Legacies receivable
141,712
-
357,347
2,893
Donations and gifts
Donations
196,644
2,893
Gift aid
18,991
-
215,635
2,893		 Total
Unrestricted
Restricted
funds
funds
2023
2022
2022
£
£
£
218,528
143,610
20,796
141,712
793,114
-
360,240
936,724
20,796
199,537
130,775
20,796
18,991
12,835
-
218,528
143,610
20,796		 Total
2022
£
164,406
793,114
957,520
151,571
12,835
164,406

St Francis Leprosy Guild Annual Report 2023

ST FRANCIS LEPROSY GUILD

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2023

3
4		 Investments
Unrestricted Unrestricted
funds
funds
2023
2022
£
£
Income from listed investments
19,208
20,187
Interest receivable
11,959
2,122
31,167
22,309
Raising funds
Unrestricted Unrestricted
funds
funds
2023
2022
£
£
Fundraising and publicity
Marketing
145,889
136,901
Online fundraising costs
404
258
Depreciation
3,725
3,023
Support costs
169,138
110,794
Fundraising and publicity
319,156
250,976
Investment management
9,864
9,230
329,020
260,206		 Investments
Unrestricted Unrestricted
funds
funds
2023
2022
£
£
Income from listed investments
19,208
20,187
Interest receivable
11,959
2,122
31,167
22,309
Raising funds
Unrestricted Unrestricted
funds
funds
2023
2022
£
£
Fundraising and publicity
Marketing
145,889
136,901
Online fundraising costs
404
258
Depreciation
3,725
3,023
Support costs
169,138
110,794
Fundraising and publicity
319,156
250,976
Investment management
9,864
9,230
329,020
260,206
250,976
9,230
260,206

St Francis Leprosy Guild Annual Report 2023

26

ST FRANCIS LEPROSY GUILD

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023

5 Charitable activities

Training
Research Active case
finding
Care grants
Total
2023
2023
2023
2023
2023
£
£
£
£
£
Grant funding of
activities (see note 6)
2,410
60,020
108,650
212,072
383,152
Share of support costs
(see note 7)
967
25,293
45,752
89,088
161,100
Share of governance
costs (see note 7)
48
1,262
2,283
4,444
8,037
3,425
86,575
156,685
305,604
552,289
Analysis by fund
Unrestricted funds
3,425
86,575
153,792
305,604
549,396
Restricted funds
-
-
2,893
-
2,893
3,425
86,575
156,685
305,604
552,289
For the year ended 31 December 2022
Training
Research Active case
finding
Care grants Emergency
grants
£
£
£
£
£
Grant funding of activities
(see note 6)
9,222
40,000
108,787
179,973
37,897
Share of support costs (see
note 7)
2,543
10,783
29,400
48,728
10,275
Share of governance costs
(see note 7)
227
960
2,620
4,342
916
11,992
51,743
140,807
233,043
49,088
Analysis by fund
Unrestricted funds
11,992
51,743
132,984
220,070
49,088
Restricted funds
-
-
7,823
12,973
-
11,992
51,743
140,807
233,043
49,088		 Total
2022
£
375,879
101,729
9,065
486,673
465,877
20,796
486,673
Total
2022
£
375,879
101,729
9,065
486,673
465,877
20,796
486,673

St Francis Leprosy Guild Annual Report 2023

27

ST FRANCIS LEPROSY GUILD

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023

6 Grants payable

Training Research Active case Care grants Total
finding
2023 2023 2023 2023 2023
£ £ £ £ £
Grants to institutions:
Grants 2,410 60,020 108,650 212,072 383,152

For the year ended 31 December 2022

Grants to institutions:
Grants
Support costs
Staff costs
Consultancy
Rent, utilities and
telephone
Postage and stationery
IT support costs
Insurance
Travelling
Training
Bank charges
Sundries
Legal and professional
Analysed between
Fundraising
Charitable activities		 Training
Research Active case
finding
Care grants Emergency
grants
£
£
£
£
£
9,222
40,000
108,787
179,973
37,897
Support
costs
Governance
costs
2023
Support
costs
Governance
costs
£
£
£
£
£
190,137
-
190,137
163,740
-
95,701
-
95,701
-
-
11,751
-
11,751
7,667
-
5,017
-
5,017
3,589
-
6,371
-
6,371
8,631
-
1,809
-
1,809
1,388
-
5,498
-
5,498
9,672
-
309
-
309
1,201
-
853
-
853
1,126
-
4,755
-
4,755
6,444
-
-
16,074
16,074
-
18,130
322,201
16,074
338,275
203,458
18,130
161,101
8,037
169,138
101,729
9,065
161,100
8,037
169,137
101,729
9,065
322,201
16,074
338,275
203,458
18,130		 Total
2022
£
375,879
2022
£
163,740
-
7,667
3,589
8,631
1,388
9,672
1,201
1,126
6,444
18,130
221,588
110,794
110,794
221,588

7 Support costs

St Francis Leprosy Guild Annual Report 2023

28

ST FRANCIS LEPROSY GUILD

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023

8 Trustees

None of the trustees (or any persons connected with them) received any remuneration or benefits from the Trust during the year.

There were no trustee expenses incurred in the year (2022 - none).

9 Employees

The average monthly number of employees during the year was:

Administration
Employment costs
Wages and salaries
Other pension costs		 2023
Number
4
2023
£
185,954
4,183
190,137		 2022
Number
4
2022
£
159,581
4,159
163,740

The charity considers its key management personnel comprises the trustees and the Chief Executive Officer. During the year the Chief Executive Officer received remuneration of £23,847 (2022 - £63,038), pension contributions of £751 (2022 - £1,891) and employers' national insurance of £2,872 (2022 - £7,849).

The number of employees whose annual remuneration was more than £60,000 is as follows:

2023 2022
Number Number
£60,001 to £70,000 - 1

10 Net gains/(losses) on investments

Unrestricted Unrestricted Unrestricted Unrestricted
funds funds
2023 2022
£ £
Revaluation of investments 16,724 (112,831)
Gain/(loss) on sale of investments (5,660) (32,761)
11,064 (145,592)

St Francis Leprosy Guild Annual Report 2023

29

ST FRANCIS LEPROSY GUILD

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023

11 Taxation

The charity is exempt from tax on income and gains falling within section 505 of the Taxes Act 1988 or section 252 of the Taxation of Chargeable Gains Act 1992 to the extent that these are applied to its charitable objects.

12 Tangible fixed assets

Tangible fixed assets
Computers
£
Cost
At 1 January 2023 9,229
At 31 December 2023 9,229
Depreciation and impairment
At 1 January 2023 5,304
Depreciation charged in the year 3,725
At 31 December 2023 9,029
Carrying amount
At 31 December 2023 200
At 31 December 2022 3,925

13 Fixed asset investments

Listed Cash in Total
investments portfolio
£ £
Cost or valuation
At 1 January 2023 676,754 45,755 722,509
Additions 182,114 - 182,114
Valuation changes 16,724 - 16,724
Disposals (156,523) (16,570) (173,093)
At 31 December 2023 719,069 29,185 748,254
Carrying amount
At 31 December 2023 719,069 29,185 748,254
At 31 December 2022 676,754 45,755 722,509
2023 2022
£ £
Investments at fair value comprise:
Cost 704,975 679,384
Valuation 43,279 43,125
748,254 722,509

St Francis Leprosy Guild Annual Report 2023

30

ST FRANCIS LEPROSY GUILD

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2023

13
Fixed asset investments
14
Debtors
Amounts falling due within one year:
Prepayments and accrued income
15
Creditors: amounts falling due within one year
Other taxation and social security
Accruals and deferred income		 (Continued)
2023
2022
£
£
18,116
14,760
2023
2022
£
£
-
5,405
53,976
13,744
53,976
19,149		 (Continued)
2023
2022
£
£
18,116
14,760
2023
2022
£
£
-
5,405
53,976
13,744
53,976
19,149
2022
£
5,405
13,744
19,149

16 Retirement benefit schemes

Defined contribution schemes

The Trust operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the Trust in an independently administered fund.

The charge to profit or loss in respect of defined contribution schemes was £4,183 (2022 - £4,159).

St Francis Leprosy Guild Annual Report 2023

31

ST FRANCIS LEPROSY GUILD

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023

17 Designated funds

The income funds of the charity include the following designated funds which have been set aside out of unrestricted funds by the trustees for specific purposes:

Balance at
1 January 2022
Resources
expended
£
£
Active case
finding grants
240,000
(140,807)
Maintenance
projects /
Assisi grants
-
-
Emergency
grants
30,000
(30,000)
Recruitment /
fundraising
143,000
(143,000)
Training
10,000
(1,201)
Capital
projects
15,000
(15,000)
Support
-
-
438,000
(330,008)		 Transfers
Balance at
1 January 2023
Resources
expended
£
£
£
9,458
108,651
(108,651)
214,466
214,466
(214,466)
-
-
-
-
-
-
(8,799)
-
-
20,000
20,000
(20,000)
10,504
10,504
(5,498)
245,629
353,621
(348,615)		 Transfers
Balance at
31 December
2023
£
£
-
-
-
-
-
-
-
-
-
-
-
-
(5,006)
-
(5,006)
-

The designated funds are: Active Case Finding Grants This is a designated fund for finding new projects that are considered worth funding. Maintenance Projects / Assisi Grants This designated fund is to ensure that annual grant commitments can be met for the following year. Emergency Grants

This designated fund is to ensure that emergency grants are available to those that require urgent assistance Recruitment/fundraising This designated fund is to ensure there are funds available to cover the next twelve months costs. Training

This designated fund has been set aside for training costs. Capital Projects

This designated fund has been set aside for capital projects. Support

This designated fund has been set aside for international membership fees and travel costs for partner projects.

18 Related party transactions

There were no disclosable related party transactions during the year (2022 - none).

St Francis Leprosy Guild Annual Report 2023

32

ST FRANCIS LEPROSY GUILD

NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)

FOR THE YEAR ENDED 31 DECEMBER 2023

19
Cash generated from operations
2023
£
(Deficit)/surpus for the year
(478,838)
Adjustments for:
Investment income recognised in statement of financial activities
(31,167)
Loss on disposal of investments
5,660
Fair value gains and losses on investments
(16,724)
Depreciation and impairment of tangible fixed assets
3,725
Movements in working capital:
(Increase)/decrease in debtors
(3,356)
Increase/(decrease) in creditors
34,827
Cash (absorbed by)/generated from operations
(485,873)
20
Analysis of changes in net funds
The Trust had no debt during the year.		 2022
£
87,358
(22,309)
32,761
112,831
3,023
4,528
(14,347)
203,845

St Francis Leprosy Guild Annual Report 2023

33